Voya Investment Management LLC Cure Vac N.V. Transaction History

Voya Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.18 - $19.41 $342,231 - $504,000	-25,966 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$14.73 - $35.25 $7,527 - $18,012	-511 Reduced 1.93%	25,966 $509,000
Q4 2021 Feb 14, 2022	BUY	$33.72 - $48.22 $321,284 - $459,440	9,528 Added 56.22%	26,477 $908,000
Q3 2021 Nov 15, 2021	SELL	$49.26 - $74.5 $16,994 - $25,702	-345 Reduced 1.99%	16,949 $926,000
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $984,201 - $2.21 Million	17,294 New	17,294 $1.27 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $538M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.